| | Increasing ANNV (> 4) | Stable ANNV (-4 to 4) | Decreasing ANNV (< -4) |
|---|
Parameter | PCa (n = 22) | BPH (n = 16) | p-value | PCa (n = 17) | BPH (n = 124) | p-value | PCa (n = 10) | BPH (n = 10) | p-value |
|---|
Age (years) | 65* | 68.5 | 0.61 | 70 | 68 | 0.7 | 62 | 64 | 0.29 |
tPSA (ng/mL) | 8.3 | 6.8 | 0.17 | 10.2 | 5.3 | 0.002 | 5.5 | 4.35 | 0.5 |
%fPSA (%) | 8.0*$
| 13.15 | 0.017 | 15.15 | 17.4 | 0.85 | 11.2 | 13.8 | 0.1 |
Volume (mL) | 33.5* | 36.5* | 0.34 | 50 | 53.5$
| 0.87 | 30.5* | 34* | 0.26 |
- The p-value is given for the comparison between the respective PCa and BPH patients (Mann-Whitney U Test)
- *significantly different to the respective patients in the stable group (P < 0.05; Mann-Whitney U Test)
-
§significantly different to the respective patients in the decreasing group (P < 0.05; Mann-Whitney U Test)
- The Kruskal-Wallis Test for the PCa patients between all 3 groups showed only for %fPSA (p = 0.014) significant differences but not for age (p = 0.32), tPSA (p = 0.16) or volume (p = 0.98).
- The Kruskal-Wallis Test for the BPH patients between all 3 groups showed for volume (p = 0.022) significant differences but not for age (p = 0.31), tPSA (p = 0.61) or %fPSA (p = 0.17).
